Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Rash
ADR ID BADD_A03695
ADR Hierarchy
23      Skin and subcutaneous tissue disorders
23.03      Epidermal and dermal conditions
23.03.13      Rashes, eruptions and exanthems NEC
23.03.13.001      Rash
Description Diseases in which skin eruptions or rashes are a prominent manifestation. Classically, six such diseases were described with similar rashes; they were numbered in the order in which they were reported. Only the fourth (Duke's disease), fifth (ERYTHEMA INFECTIOSUM), and sixth (EXANTHEMA SUBITUM) numeric designations survive as occasional synonyms in current terminology. [MeSH]
MedDRA Code 10037844
MeSH ID D005076
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Dry rash face | Dry rash neck | Eruption | Eruption facial | Eruption of limbs | Exanthem | Exanthema | Extensive rash of forearm | Extensive rash of legs | Facial rash | Generalised eruption | Generalised rash | Hand rash | Neck rash | Patchy rash | Rash | Rash (nonspecific) | Rash all over | Rash both legs | Rash face | Rash generalised | Rash in the outer ear | Rash NOS | Rash on face | Rash on legs & arms | Rash over arms | Rash trunk & limbs | Skin eruption | Skin rash | Widespread non-itchy dull red patchy rash | Widespread rash | Rash aggravated | Generalized rash | Periocular rash | Efflorescence | Exanthema generalised | Exanthema facial | Exanthema generalized | Rash trunk | Generalized eruption | Localised rash | Localized rash | Rash peripheral | Rash recurrent | Palmoplantar rash | Painful rash | Pigmented rash | Rash on leg | Scalp rash | Skin breakout | Periorbital rash | Evanescent skin rash | Groin rash | Hypopigmented rash | Skin Rash | Rash, Skin
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01093Hydroflumethiazide--
BADD_D01095Hydrogen iodide--
BADD_D01096Hydromorphone--
BADD_D01099Hydroxocobalamin--
BADD_D01100Hydroxocobalamin acetate--
BADD_D01101Hydroxybutanedial--
BADD_D01102Hydroxybutanoic acid--
BADD_D01103Hydroxychloroquine0.082371%
BADD_D01104Hydroxychloroquine sulfate--
BADD_D01106Hydroxyprogesterone--
BADD_D01108Hydroxyproline--
BADD_D01110Hydroxyurea--
BADD_D01111Hydroxyzine--
BADD_D01113Hydroxyzine pamoate--
BADD_D01114Hyoscyamine--
BADD_D01116Ibandronate sodium--
BADD_D01117Ibandronic acid--
BADD_D01118Ibritumomab tiuxetan--
BADD_D01119Ibrutinib0.026102%
BADD_D01120Ibuprofen0.000144%
BADD_D01123Icatibant acetate--
BADD_D01124Icodextrin--
BADD_D01126Icosapent ethyl-
BADD_D01127Idarubicin--
BADD_D01128Idarubicin hydrochloride--
BADD_D01129Idarucizumab--
BADD_D01130Idelalisib--
BADD_D01132Idursulfase--
BADD_D01133Ifosfamide--
BADD_D01134Iloperidone--
The 27th Page    First    Pre   27 28 29 30 31    Next   Last    Total 60 Pages
ADReCS-Target
ADR Term Drug Name Target